Effects of Tangshenning on MMP-9、TIMP-1 Expression of Renal Tissue in Type 2 Diabetic KK-ay Mice

邹大威,高彦彬,刘迎新,耿建国,彭麒朕,龚慕辛,朱智耀,李娇阳,杨鑫伟,王晓磊
DOI: https://doi.org/10.3969/j.issn.1674-1749.2015.11.013
2015-01-01
Abstract:[Abstract ]Objective To explore effects of Tangshenning on expression of matrix metalloproteinase-9 (MMP-9)、tissue inhibitor of metalloproteinase 1 ( TIMP-1) in diabetic nephropathy mice model. Methods Diabetic male KK-Ay mice were randomLy divided into three groups: the model group (n= 20),the valsartan group( n = 20) and the Tangshenning group ( n = 20). Male C57BL / 6J (n=20)mice were designed as the control group. After intervention with Tangshenning and valsartan for 12 weeks,serum creatinine (Scr) and serum urea nitrogen(BUN) were examined. Expression of MMP-9, TIMP-1 were accessed by Realtime-Pcr , Western Blot and Immunohistochemistry. Results Compared with control group, BUN and SCr were significantly increased (P<0. 05), while them of mice in valsartan and tangshenning group were decreased compared with model group(P<0. 05). Compared with the control group, the protein and gene expression of MMP9 and TIMP-1 both have the same trend in model group, the expression of MMP9 were decreased significantly and the expression of TIMP-1 were increased significantly (P<0. 05). Through the treatment of Tangshenning and valsartan for 12 weeks, the expression of TIMP-1 were down-regulated and the expression of MMP-9 were up-regulated in diabeticKK-Ay mice(P<0. 05). Conclusion Tangshenning could protect renal function and delay the process of renal fibrosis partly through regulating extracellular matrix degradation enzymes MMP-9 / TIMP-1 expression.
What problem does this paper attempt to address?